Our Pipeline

Portfolio

Gene edited and engineered cellular therapies

AMA-020
Primary resected & metastatic solid tumors
Through IND-enabling
AMA-021
Primary resected & metastatic solid tumors
Through POC
AMA-022
Variety of solid tumors
Through POC
AMA-023
Primary & metastatic solid tumors
Through POC
AMA-024
Primary & metastatic solid tumors
Through POC
AMA-025
Variety of solid tumors
Through POC
Bars show the furthest stage each candidate has cleared across the development pathway.